Promoting and facilitating strategies to improve cardiovascular health worldwide

 
 
 
 
 
 

 

newsfeed

Pegozafermin lowers high triglycerides, non-HDL and ApoB vs. placebo in small trial

Posted on June 09, 2023

Pegozafermin, a fibroblast growth factor 21 analog, reduced atherogenic particles in patients with severe hypertriglyceridemia and improved liver fat and insulin resistance... more

CAC screening, follow-up care lacking among Black patients in small study

Posted on June 09, 2023

Black patients who undergo coronary artery calcium scoring received less post-screening care and had more adverse CV events compared with white patients... more

Xenotransplantation: Are we ready for clinical trials in humans?

Posted on June 08, 2023

For this month’s Infectious Disease News cover story, we touched base with experts in transplant medicine and transplant infectious diseases to discuss... more

Addressing disparities in ASCVD within the US South Asian population

Posted on June 08, 2023

The South Asian population in the U.S. is one of the fastest-growing minority ethnic groups, and these individuals are a particularly higher-risk... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •   Alberto Lorenzatti

    VP / President Elect

    Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more

  •   Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    President

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more

  •   Georg Noll

    Treasurer

      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more